| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H18ClNO2 |
| Molecular Weight | 255.741 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)NC(C)(C)CC1=CC=C(Cl)C=C1
InChI
InChIKey=TZWKUQDQKPYNLL-UHFFFAOYSA-N
InChI=1S/C13H18ClNO2/c1-4-17-12(16)15-13(2,3)9-10-5-7-11(14)8-6-10/h5-8H,4,9H2,1-3H3,(H,15,16)
| Molecular Formula | C13H18ClNO2 |
| Molecular Weight | 255.741 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cloforex (Oberex) is an anorectic of the amphetamine class. It is a prodrug to chlorphentermine. It is an appetite-reducing agent, used to treat obesity. The Ministry of Health withdrew preparations containing cloforex as a precautionary measure pending scientific evidence of a relationship between their use and the development of pulmonary hypertension. In Europe Cloforex was approved in 1968 and discontinued in 1969.
